Login / Signup

Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma.

Jongmoo ParkJinhong JungDaegeun KimIn-Hye JungJin-Hong ParkJong Hoon KimSang-Wook LeeSang Min Yoon
Published in: BMC cancer (2018)
The 2-week schedule of hypofractionated radiotherapy for recurrent HCC exhibited good local control and acceptable treatment-related toxicity during the long-term follow-up period. Thus, this fractionation schedule can be a potential salvage treatment option for recurrent HCC, particularly for tumors located close to a radiosensitive gastrointestinal organ.
Keyphrases
  • radiation therapy
  • early stage
  • locally advanced
  • small cell lung cancer
  • squamous cell carcinoma
  • randomized controlled trial
  • climate change
  • rectal cancer
  • study protocol
  • human health
  • placebo controlled